BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Leukocyte, Anticancer prodrugs, Cisplatin, rs6983267, DNMT1, calcium channel activity)
Bookmark Forward

QuickView for CACNA1D;jsessionid=2A340C388FA59F40E4185E4CF05634CA;jsessionid=481A6E5D88FB4D6644FD0D579B6DB0CA;jsessionid=220B57E4DEB640160932C756584B8319;jsessionid=81F32A02FA9B749BD13AAE6EE167BA5C;jsessionid=340B223498E42DF560F8425EC9DC3006;jsessionid=64D09D7729381AF6DB52AE0E510ED485;jsessionid=DA8390503CD68871E8D447046F2E8DA4 (gene)


Body Atlas

Most Correlated Tissues

  1. Cerebellum peduncles
  2. Skeletal muscle psoas
  3. Atrioventricular node
  4. Cingulate cortex
  5. Tongue
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Disorder of adrenal gland
  2. Neurological finding
  3. Infection by Encephalitozoon cuniculi
  4. General adaptation syndrome
  5. Pyloric ulcer
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. senkirkine
  2. Pyrrolizidine Alkaloids
  3. 8-(3-Chlorostyryl)-1,3,7-trimethylxanthine
  4. Carbon Black
  5. Organophosphorus Compounds
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. RBPMS
  2. MARCH6
  3. TMPRSS2
  4. AXL
  5. HNRNPA0
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. CaV1.3 channel clusters characterized by live-cell and isolated plasma membrane nanoscopy.
  2. Association between CACNA1D polymorphisms and hypospadias in a southern Chinese population.
  3. Undiagnosed Disease Network collaborative approach in diagnosing rare disease in a patient with a mo…
  4. CACNA1D-Related Channelopathies: From Hypertension to Autism.
  5. The human channel gating-modifying A749G CACNA1D (Cav1.3) variant induces a neurodevelopmental syndr…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

There were no clinical trials for CACNA1D;jsessionid=2A340C388FA59F40E4185E4CF05634CA;jsessionid=481A6E5D88FB4D6644FD0D579B6DB0CA;jsessionid=220B57E4DEB640160932C756584B8319;jsessionid=81F32A02FA9B749BD13AAE6EE167BA5C;jsessionid=340B223498E42DF560F8425EC9DC3006;jsessionid=64D09D7729381AF6DB52AE0E510ED485;jsessionid=DA8390503CD68871E8D447046F2E8DA4
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.